D. Western Therapeutics Institute, Inc. (FRA:6DW)
0.540
+0.020 (3.85%)
At close: Nov 28, 2025
FRA:6DW Cash Flow Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | - | -1,288 | -826 | -440 | -159 | -289 | Upgrade
|
| Depreciation & Amortization | - | 49 | 48 | 46 | 45 | 44 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 6 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | 12 | 100 | - | - | Upgrade
|
| Other Operating Activities | - | -3 | 2 | 1 | -3 | - | Upgrade
|
| Change in Accounts Receivable | - | -7 | 53 | -113 | -9 | 11 | Upgrade
|
| Change in Inventory | - | -14 | 22 | 9 | -30 | 1 | Upgrade
|
| Change in Accounts Payable | - | -74 | 95 | 22 | 4 | 12 | Upgrade
|
| Change in Other Net Operating Assets | - | 38 | 2 | 21 | -24 | 5 | Upgrade
|
| Operating Cash Flow | - | -1,299 | -586 | -354 | -176 | -216 | Upgrade
|
| Capital Expenditures | - | -9 | -12 | -9 | -2 | -5 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -1 | -2 | - | - | - | Upgrade
|
| Investment in Securities | - | - | - | -130 | -109 | -7 | Upgrade
|
| Other Investing Activities | - | - | -1 | - | - | -1 | Upgrade
|
| Investing Cash Flow | - | -10 | -15 | -139 | -111 | -13 | Upgrade
|
| Long-Term Debt Issued | - | 886 | 166 | 913 | - | 100 | Upgrade
|
| Long-Term Debt Repaid | - | -1,034 | -120 | -120 | -120 | -120 | Upgrade
|
| Net Debt Issued (Repaid) | - | -148 | 46 | 793 | -120 | -20 | Upgrade
|
| Issuance of Common Stock | - | 715 | 88 | 87 | 15 | 1,024 | Upgrade
|
| Other Financing Activities | - | - | - | -13 | 1 | - | Upgrade
|
| Financing Cash Flow | - | 567 | 134 | 867 | -104 | 1,004 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | 28 | 17 | -6 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | 1 | - | -2 | - | -2 | Upgrade
|
| Net Cash Flow | - | -741 | -467 | 400 | -374 | 767 | Upgrade
|
| Free Cash Flow | - | -1,308 | -598 | -363 | -178 | -221 | Upgrade
|
| Free Cash Flow Margin | - | -277.71% | -139.72% | -81.03% | -42.99% | -62.25% | Upgrade
|
| Free Cash Flow Per Share | - | -37.24 | -18.82 | -12.25 | -6.07 | -8.13 | Upgrade
|
| Cash Interest Paid | - | 5 | 2 | 2 | 4 | 4 | Upgrade
|
| Cash Income Tax Paid | - | 1 | 1 | 1 | 1 | 1 | Upgrade
|
| Levered Free Cash Flow | - | -871.38 | -317 | -225.13 | -126 | -129.75 | Upgrade
|
| Unlevered Free Cash Flow | - | -868.25 | -315.75 | -223.25 | -123.5 | -127.25 | Upgrade
|
| Change in Working Capital | - | -57 | 172 | -61 | -59 | 29 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.